Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Light for Life<br />
BEACON<br />
07.00 Number of employee and salary:<br />
The company paid an aggregate amount more than 3,000 to1042 employee. The different ranges salaried employees<br />
are stated bellow:<br />
Salary Range<br />
No. of Employee<br />
3,000 to 10,000 1040<br />
10,000 to 15,000 165<br />
15,000 to 25,000 40<br />
25,000 to 50,000 09<br />
50,000 above 10<br />
Total 1264<br />
08.00 Share Capital of the Company:<br />
As on 30.06.2009, the paid-up share capital of the Company was Tk 60,00,00,000 divided into 6,00,00,000 ordinary<br />
shares of Tk.10.00 each. Subsequently the Company issued 100,000,000 ordinary shares of Tk. 10.00 each<br />
amounting to Tk. 1,000,000,000.00 on 24.09.2009, which consent has been accorded by the Securities and Exchange<br />
Commission on 04.08.2009 and issued 30,000,000 ordinary shares of Tk. 10.00 each amounting to Tk.<br />
300,000,000.00 on 30.12.2009, which consent has been accorded by the Securities and Exchange Commission on<br />
25.10.2009. Considering the above events, the paid-up capital of the Company stands at Tk. 1,900,000,000.00.<br />
Dated: Dhaka<br />
30 December 2009<br />
Sd/-<br />
(M. A. Malek Siddiqui Wali & Co.)<br />
Chartered Accountants<br />
9.00 There is no amount due from Directors, Managers and Officers of the company.<br />
No amount is due from any associate undertaking and related parties as on 30-06-2009.<br />
No provision has been made for any debt.<br />
Total amount of receivable due from local customers.<br />
10.00<br />
11.00 Restated EPS =<br />
18,473,433<br />
190,000,000 = 0.10<br />
Restated EPS Calculated considering the increased paid up capital of Tk.130 crore after the balance sheet.<br />
12.00<br />
Managing Director & Director has spent fund of Tk. 59.75 crore from their own source to construct factorybuilding,<br />
development of factory land and to purchase machineries. Subsequently these assets has transferred<br />
to <strong>Beacon</strong> <strong>Pharmaceuticals</strong> <strong>Ltd</strong>. by Vendors agreement and against this asset they have received 59,75,000<br />
fully paid ordinary shares @ Tk. 100.00 each in two phase (1st phase 4,75,000 fully paid ordinary shares @ Tk.<br />
100.00 each vendors agreement date 20th October 2003 and 2nd phase 55,00,000 fully paid ordinary shares<br />
@ Tk. 100.00 each vendors agreement date 20th April 2005).<br />
The company pays salaries & allowances on accrual basis i.e, current's month salary is accrued for the month<br />
and it is pay in immediate next month. The accrued salary & allowances of Tk. 68,72,592 was payable for the<br />
month of June'09 and subsequently it was paid in next month so at the date of signing of audit report above<br />
accrued salary & allowances has paid.<br />
Dated: Dhaka<br />
23 March 2010<br />
Sd/-<br />
(M. A. Malek Siddiqui Wali & Co.)<br />
Chartered Accountants<br />
75<br />
PROSPECTUS